Company: INMB
Filing Date: 2025-06-30
Form Type: 424B5
Source: 0001213900-25-059298
Chunk: 11

Company: Inmune Bio, Inc.
Filing Date: 2025-06-30
Form: 424B5
Chunk 11
---

funded program is also subject to certain reporting requirements, compliance with which may require us to expend substantial resources.
In addition, the U.S. government requires that any products embodying any of these inventions or produced through the use of any of these
inventions be manufactured substantially in the United States. This preference for U.S. industry may be waived by the federal agency that
provided the funding if the owner or assignee of the intellectual property can show that reasonable but unsuccessful efforts have been
made to grant licenses on similar terms to potential licensees that would be likely to manufacture substantially in the United States
or that under the circumstances domestic manufacture is not commercially feasible. This preference for U.S. industry may limit our ability
to contract with non-U.S. product manufacturers for products covered by such intellectual property.

<div align='center'>S-5

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</div>

This prospectus supplement
and the documents incorporated by reference into this prospectus supplement contain certain forward-looking statements within the meaning
of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, in reliance
upon the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation,
statements regarding: future events concerning our business, including our potential acquisition of Amiga, and to our future revenues,
operating results and financial condition; and other statements containing forward-looking words, such as “believes”, “may”,
“could”, “would”, “will”, “expects”, “intends”, “estimates”, “anticipates”,
“plans”, “seeks”, or “continues” or the negative thereof or variations thereon or similar terminology
(although not all forward-looking statements contain these words). Such forward-looking statements are based on the beliefs of our management
as well as assumptions made by and information currently available to our management. Readers should not put undue reliance on these forward-looking
statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified;
therefore, our actual results may differ materially from those described in any forward-looking statements. Any forward-looking statements
are qualified in their entirety by reference to the factors discussed throughout this prospectus supplement.

Factors that might cause these
differences include, but are not limited to, those described in our Annual Report on Form 10-K for